| AIDS treatment with novel anti-HIV compounds improved by nanotechnology. | |
| | |
MedLine Citation:
|
PMID: 20373061 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The first International Symposium of Nanomedicine on AIDS "AIDS Treatment with Novel Anti-HIV compounds Improved by Nanotechnology" was held November 19-20, 2009 in Beijing, China. This symposium provided an international forum for presentation and discussion of exciting new advances in the emerging research area of nanobiomedical research on AIDS treatment as the focus point, as well as some issues in relevant fields such as nanobiomedical research on tumor treatment and safety evaluation of nanomedicines. Key highlights of the symposium include (1) reviewing current status of nanobiotechnology programs and their relations, more or less, with AIDS treatment; (2) reviewing current AIDS epidemiology in China and examining effectiveness and efficiency of current prevention and treatment strategies; (3) highlighting the obstacles to improve AIDS prevention and treatment, and (4) exploring innovative ways for nanotechnology to advance AIDS treatment, especially to combat HIV resistance to drugs. |
| | |
Authors:
|
Xiaowei Ma; Dongliang Wang; Yan Wu; Rodney J Y Ho; Lee Jia; Peixuan Guo; Liming Hu; Gengmei Xing; Yi Zeng; Xing-Jie Liang |
Publication Detail:
|
Type: Congresses; Research Support, Non-U.S. Gov't Date: 2010-04-06 |
Journal Detail:
|
Title: The AAPS journal Volume: 12 ISSN: 1550-7416 ISO Abbreviation: AAPS J Publication Date: 2010 Sep |
Date Detail:
|
Created Date: 2010-06-22 Completed Date: 2010-10-21 Revised Date: 2011-10-13 |
Medline Journal Info:
|
Nlm Unique ID: 101223209 Medline TA: AAPS J Country: United States |
Other Details:
|
Languages: eng Pagination: 272-8 Citation Subset: IM |
Affiliation:
|
Laboratory of Nanomedicine and Nanosafety, Division of Nanomedicine and Nanobiology, National Center for Nanoscience and Technology, Beijing, People's Republic of China. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Anti-HIV Agents
/
administration & dosage,
pharmacology,
therapeutic use* Drug Carriers HIV Infections / drug therapy*, prevention & control HIV-1 / drug effects Humans Nanotechnology* |
| Grant Support | |
ID/Acronym/Agency:
|
R01 AI077390-01A2/AI/NIAID NIH HHS; R01 AI077390-02/AI/NIAID NIH HHS; R01 AI077390-03/AI/NIAID NIH HHS; R01 AI077390-04/AI/NIAID NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Anti-HIV Agents; 0/Drug Carriers |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Prospective evaluation of solitary thyroid nodule on 18F-FDG PET/CT and high-resolution ultrasonogra...
Next Document: DDSolver: an add-in program for modeling and comparison of drug dissolution profiles.